MeSH tree: D13.444.735.790
Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors—the most common solid cancers in young men—has the potential to improve patient ...
Mar 25, 2025
0
105
More than 120 million Americans suffer from diabetes or pre-diabetes. Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer, and TNBC patients with obesity-driven diabetes often have worse outcomes.
Mar 6, 2025
0
17
Firefighters who fight fires in wildland urban interface zones, where undeveloped and developed land meet, appear to experience genetic changes that may help explain their elevated risk for certain cancers and other diseases, ...
Mar 5, 2025
0
14
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP) have studied variations in mRNA length during the progression of atherosclerosis in a mouse model. ...
Feb 20, 2025
0
9
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or inactivating genes. Precisely fixing disease-causing mutations is far more difficult. This is especially ...
Feb 12, 2025
0
40
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai researcher of a Phase II trial.
Feb 12, 2025
0
33
Researchers are investigating the link between mindfulness and health, offering potential new options for the treatment and early detection of cancer.
Feb 5, 2025
0
18
What does it take to design a new needle for medical use? When the needle needs to be much thinner and sharper than any commercially existing needle and designed to deliver treatments to a previously inaccessible tissue, ...
Dec 20, 2024
0
24
Peter Mac scientists have found a way to use the powerful gene editing tool CRISPR to silence cancer-causing gene mutations which, up to now, have remained off-limits to targeted drugs.
Dec 19, 2024
0
44
A new pathology tool created at Yale harnesses barcode technology and shows potential for use in cancer diagnoses. The technology, Patho-DBiT (pathology-compatible deterministic barcoding in tissue), was discussed in a new ...
Nov 20, 2024
0
13
